Aurobindo Pharma subsidiary Eugia Steriles' new injectables facility gets first product approval by FDA

Aurobindo Pharma Ltd on September 11 said a new injectable facility of Eugia Steriles Private Limited, which was inspected by the US Food and Drug Administration (FDA), received its first product approval.

Eugia Steriles Private Limited is a 100 percent subsidiary of Eugia Pharma Specialities Limited and a step-down subsidiary of Aurobindo Pharma.

A press release from the drugmaker said the plant located in Andhra Pradesh was inspected by the US regulator from March 28 to April 5, this year.

The FDA approved Lidocaine Hydrochloride Injection, USP, 1% (10 mg/mL) and 2% (20 mg/mL).